Global Gastrointestinal Therapeutics Market Insights and Forecast to 2028

  • Report ID:165041
  • Industry Name: Medical Care
  • Publishing Date: Feb-22
  • No. of Pages: 111
                              
Gastrointestinal Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Oral Parenteral Segment by Application IBD Irritable Bowel Syndrome (IBS) By Company AbbVie Allergan Johnson & Johnson Takeda Novartis Pfizer Merck F. Hoffmann-La Roche Eli Lilly AstraZeneca Procter & Gamble Tillotts Pharma Takeda GlaxoSmithKline Amgen By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Oral 1.2.3 Parenteral 1.3 Market by Application 1.3.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 IBD 1.3.3 Irritable Bowel Syndrome (IBS) 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gastrointestinal Therapeutics Market Perspective (2017-2028) 2.2 Gastrointestinal Therapeutics Growth Trends by Region 2.2.1 Gastrointestinal Therapeutics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Gastrointestinal Therapeutics Historic Market Size by Region (2017-2022) 2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028) 2.3 Gastrointestinal Therapeutics Market Dynamics 2.3.1 Gastrointestinal Therapeutics Industry Trends 2.3.2 Gastrointestinal Therapeutics Market Drivers 2.3.3 Gastrointestinal Therapeutics Market Challenges 2.3.4 Gastrointestinal Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gastrointestinal Therapeutics Players by Revenue 3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2017-2022) 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2017-2022) 3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue 3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio 3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2021 3.5 Gastrointestinal Therapeutics Key Players Head office and Area Served 3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service 3.7 Date of Enter into Gastrointestinal Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gastrointestinal Therapeutics Breakdown Data by Type 4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2017-2022) 4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028) 5 Gastrointestinal Therapeutics Breakdown Data by Application 5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Gastrointestinal Therapeutics Market Size (2017-2028) 6.2 North America Gastrointestinal Therapeutics Market Size by Type 6.2.1 North America Gastrointestinal Therapeutics Market Size by Type (2017-2022) 6.2.2 North America Gastrointestinal Therapeutics Market Size by Type (2023-2028) 6.2.3 North America Gastrointestinal Therapeutics Market Share by Type (2017-2028) 6.3 North America Gastrointestinal Therapeutics Market Size by Application 6.3.1 North America Gastrointestinal Therapeutics Market Size by Application (2017-2022) 6.3.2 North America Gastrointestinal Therapeutics Market Size by Application (2023-2028) 6.3.3 North America Gastrointestinal Therapeutics Market Share by Application (2017-2028) 6.4 North America Gastrointestinal Therapeutics Market Size by Country 6.4.1 North America Gastrointestinal Therapeutics Market Size by Country (2017-2022) 6.4.2 North America Gastrointestinal Therapeutics Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Gastrointestinal Therapeutics Market Size (2017-2028) 7.2 Europe Gastrointestinal Therapeutics Market Size by Type 7.2.1 Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022) 7.2.2 Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028) 7.2.3 Europe Gastrointestinal Therapeutics Market Share by Type (2017-2028) 7.3 Europe Gastrointestinal Therapeutics Market Size by Application 7.3.1 Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022) 7.3.2 Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028) 7.3.3 Europe Gastrointestinal Therapeutics Market Share by Application (2017-2028) 7.4 Europe Gastrointestinal Therapeutics Market Size by Country 7.4.1 Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022) 7.4.2 Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2017-2028) 8.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type 8.2.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Type (2017-2028) 8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application 8.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Application (2017-2028) 8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region 8.4.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gastrointestinal Therapeutics Market Size (2017-2028) 9.2 Latin America Gastrointestinal Therapeutics Market Size by Type 9.2.1 Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022) 9.2.2 Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028) 9.2.3 Latin America Gastrointestinal Therapeutics Market Share by Type (2017-2028) 9.3 Latin America Gastrointestinal Therapeutics Market Size by Application 9.3.1 Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022) 9.3.2 Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028) 9.3.3 Latin America Gastrointestinal Therapeutics Market Share by Application (2017-2028) 9.4 Latin America Gastrointestinal Therapeutics Market Size by Country 9.4.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022) 9.4.2 Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2017-2028) 10.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type 10.2.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Type (2017-2028) 10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application 10.3.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Application (2017-2028) 10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country 10.4.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Gastrointestinal Therapeutics Introduction 11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.1.5 AbbVie Recent Developments 11.2 Allergan 11.2.1 Allergan Company Details 11.2.2 Allergan Business Overview 11.2.3 Allergan Gastrointestinal Therapeutics Introduction 11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.2.5 Allergan Recent Developments 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction 11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.3.5 Johnson & Johnson Recent Developments 11.4 Takeda 11.4.1 Takeda Company Details 11.4.2 Takeda Business Overview 11.4.3 Takeda Gastrointestinal Therapeutics Introduction 11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.4.5 Takeda Recent Developments 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Novartis Business Overview 11.5.3 Novartis Gastrointestinal Therapeutics Introduction 11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.5.5 Novartis Recent Developments 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Gastrointestinal Therapeutics Introduction 11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.6.5 Pfizer Recent Developments 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck Gastrointestinal Therapeutics Introduction 11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.7.5 Merck Recent Developments 11.8 F. Hoffmann-La Roche 11.8.1 F. Hoffmann-La Roche Company Details 11.8.2 F. Hoffmann-La Roche Business Overview 11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction 11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.8.5 F. Hoffmann-La Roche Recent Developments 11.9 Eli Lilly 11.9.1 Eli Lilly Company Details 11.9.2 Eli Lilly Business Overview 11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction 11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.9.5 Eli Lilly Recent Developments 11.10 AstraZeneca 11.10.1 AstraZeneca Company Details 11.10.2 AstraZeneca Business Overview 11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction 11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.10.5 AstraZeneca Recent Developments 11.11 Procter & Gamble 11.11.1 Procter & Gamble Company Details 11.11.2 Procter & Gamble Business Overview 11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction 11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.11.5 Procter & Gamble Recent Developments 11.12 Tillotts Pharma 11.12.1 Tillotts Pharma Company Details 11.12.2 Tillotts Pharma Business Overview 11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction 11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.12.5 Tillotts Pharma Recent Developments 11.13 Takeda 11.13.1 Takeda Company Details 11.13.2 Takeda Business Overview 11.13.3 Takeda Gastrointestinal Therapeutics Introduction 11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.13.5 Takeda Recent Developments 11.14 GlaxoSmithKline 11.14.1 GlaxoSmithKline Company Details 11.14.2 GlaxoSmithKline Business Overview 11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction 11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.14.5 GlaxoSmithKline Recent Developments 11.15 Amgen 11.15.1 Amgen Company Details 11.15.2 Amgen Business Overview 11.15.3 Amgen Gastrointestinal Therapeutics Introduction 11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022) 11.15.5 Amgen Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Table 3. Key Players of Parenteral Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Gastrointestinal Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Gastrointestinal Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Gastrointestinal Therapeutics Market Share by Region (2017-2022) Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Gastrointestinal Therapeutics Market Share by Region (2023-2028) Table 10. Gastrointestinal Therapeutics Market Trends Table 11. Gastrointestinal Therapeutics Market Drivers Table 12. Gastrointestinal Therapeutics Market Challenges Table 13. Gastrointestinal Therapeutics Market Restraints Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Gastrointestinal Therapeutics Revenue Share by Players (2017-2022) Table 16. Global Top Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021) Table 17. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Gastrointestinal Therapeutics Product Solution and Service Table 21. Date of Enter into Gastrointestinal Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2022) Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2023-2028) Table 27. Global Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Gastrointestinal Therapeutics Revenue Share by Application (2017-2022) Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Gastrointestinal Therapeutics Revenue Share by Application (2023-2028) Table 31. North America Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million) Table 61. AbbVie Company Details Table 62. AbbVie Business Overview Table 63. AbbVie Gastrointestinal Therapeutics Product Table 64. AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 65. AbbVie Recent Developments Table 66. Allergan Company Details Table 67. Allergan Business Overview Table 68. Allergan Gastrointestinal Therapeutics Product Table 69. Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 70. Allergan Recent Developments Table 71. Johnson & Johnson Company Details Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Gastrointestinal Therapeutics Product Table 74. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 75. Johnson & Johnson Recent Developments Table 76. Takeda Company Details Table 77. Takeda Business Overview Table 78. Takeda Gastrointestinal Therapeutics Product Table 79. Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 80. Takeda Recent Developments Table 81. Novartis Company Details Table 82. Novartis Business Overview Table 83. Novartis Gastrointestinal Therapeutics Product Table 84. Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 85. Novartis Recent Developments Table 86. Pfizer Company Details Table 87. Pfizer Business Overview Table 88. Pfizer Gastrointestinal Therapeutics Product Table 89. Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 90. Pfizer Recent Developments Table 91. Merck Company Details Table 92. Merck Business Overview Table 93. Merck Gastrointestinal Therapeutics Product Table 94. Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 95. Merck Recent Developments Table 96. F. Hoffmann-La Roche Company Details Table 97. F. Hoffmann-La Roche Business Overview Table 98. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product Table 99. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 100. F. Hoffmann-La Roche Recent Developments Table 101. Eli Lilly Company Details Table 102. Eli Lilly Business Overview Table 103. Eli Lilly Gastrointestinal Therapeutics Product Table 104. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 105. Eli Lilly Recent Developments Table 106. AstraZeneca Company Details Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Gastrointestinal Therapeutics Product Table 109. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 110. AstraZeneca Recent Developments Table 111. Procter & Gamble Company Details Table 112. Procter & Gamble Business Overview Table 113. Procter & Gamble Gastrointestinal Therapeutics Product Table 114. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 115. Procter & Gamble Recent Developments Table 116. Tillotts Pharma Company Details Table 117. Tillotts Pharma Business Overview Table 118. Tillotts Pharma Gastrointestinal Therapeutics Product Table 119. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 120. Tillotts Pharma Recent Developments Table 121. Takeda Company Details Table 122. Takeda Business Overview Table 123. Takeda Gastrointestinal Therapeutics Product Table 124. Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 125. Takeda Recent Developments Table 126. GlaxoSmithKline Company Details Table 127. GlaxoSmithKline Business Overview Table 128. GlaxoSmithKline Gastrointestinal Therapeutics Product Table 129. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 130. GlaxoSmithKline Recent Developments Table 131. Amgen Company Details Table 132. Amgen Business Overview Table 133. Amgen Gastrointestinal Therapeutics Product Table 134. Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million) Table 135. Amgen Recent Developments Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2021 VS 2028 Figure 2. Oral Features Figure 3. Parenteral Features Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2021 VS 2028 Figure 5. IBD Case Studies Figure 6. Irritable Bowel Syndrome (IBS) Case Studies Figure 7. Gastrointestinal Therapeutics Report Years Considered Figure 8. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Gastrointestinal Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Gastrointestinal Therapeutics Market Share by Region: 2021 VS 2028 Figure 11. Global Gastrointestinal Therapeutics Market Share by Players in 2021 Figure 12. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2021 Figure 14. North America Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028) Figure 16. North America Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028) Figure 17. North America Gastrointestinal Therapeutics Market Size Share by Country (2017-2028) Figure 18. United States Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028) Figure 22. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028) Figure 23. Europe Gastrointestinal Therapeutics Market Size Share by Country (2017-2028) Figure 24. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Gastrointestinal Therapeutics Market Size Share by Region (2017-2028) Figure 34. China Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028) Figure 42. Latin America Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028) Figure 43. Latin America Gastrointestinal Therapeutics Market Size Share by Country (2017-2028) Figure 44. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Gastrointestinal Therapeutics Market Size Share by Country (2017-2028) Figure 50. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 54. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 55. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 56. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 57. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 58. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 59. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 61. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 62. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 63. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 64. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 65. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 66. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 67. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Purchase Report

Single User 4900
Multi User 7350
Corporate User 9800
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.